No Data
No Data
SPDR S&P Biotech ETF Options Spot-On: On September 19th, 109.02K Contracts Were Traded, With 1 Million Open Interest
On September 19th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 109.02K options for the day, of which put options accounted for 19.38% of the total
Halozyme Cut to Neutral at J.P. Morgan on Valuation
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
SPDR S&P Biotech ETF Options Spot-On: On September 18th, 131.66K Contracts Were Traded, With 933.6K Open Interest
On September 18th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 131.66K options for the day, of which put options accounted for 31.04% of the total
SPDR S&P Biotech ETF Options Spot-On: On September 17th, 82,840 Contracts Were Traded, With 904.7K Open Interest
On September 17th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 82,840 options for the day, of which put options accounted for 33.05% of the total
SPDR S&P Biotech ETF Options Spot-On: On September 13th, 100.9K Contracts Were Traded, With 867.18K Open Interest
On September 13th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 100.9K options for the day, of which put options accounted for 56.66% of the total